Jul. 15 at 1:05 AM
Key head and neck readouts from,
$PYXS's Micvo and
$GMAB's petosemtamab ahead in H2'26. An update from
$BCAX is out of the way for now I think. I took a look at PYXS in more detail. BVF LP is onboard as an investor with the recent raise.
https://seekingalpha.com/article/4921917-pyxis-oncology-the-market-might-have-already-ruled-on-micvotabart-pelidotin
